RANJAN SINHA: Open Payments
NPI 1831299353 · BRISTOL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 16 payments from 8 companies in 2025. Trend: 2023 $369 · 2024 $294 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $114 |
| E.R. Squibb & Sons, L.L.C. | 4 | $103 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $38 |
| Indivior Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: ABILIFY ASIMTUFII, COBENFY, UZEDY, VRAYLAR, SUBLOCADE, REXULTI, CAPLYTA, SPRAVATO.
Industry payments across PA — which companies pay providers there.
